Now accepting new patients · Call (954) 755-0111
Back to Procedures

Procedure

Total pancreatectomy in South Florida.

Specialist surgery to remove the entire pancreas for diffuse IPMN, multifocal pancreatic cancer, and selected hereditary syndromes — a serious operation with lifelong management.

Overview

A serious operation for diffuse pancreatic disease.

Total pancreatectomy is the operation that removes the entire pancreas — head, neck, body, and tail — along with the duodenum, distal bile duct, gallbladder, and usually the spleen. It is reserved for situations where leaving any pancreas behind would either leave cancer or pre-cancer behind, or where the remaining gland could not safely be reconnected to the intestine. The most common indications are diffuse main-duct IPMN involving the whole pancreas, multifocal pancreatic cancer, selected hereditary cancer syndromes, and severe chronic pancreatitis that has destroyed the entire gland.

Because the pancreas produces both insulin and the digestive enzymes that break down food, removing it has two permanent consequences: brittle diabetes that requires lifelong insulin, and complete loss of digestive enzyme production that requires pancreatic enzyme replacement with every meal. With careful endocrine management and a structured follow-up plan, patients can live full lives after total pancreatectomy. Our role is to ensure surgery is the right operation for the right patient, performed at a high-volume center, and supported by the multidisciplinary team that managing brittle diabetes requires.

Total pancreatectomy anatomy A simplified diagram showing the entire pancreas — head, neck, body, and tail — along with the duodenum and spleen, all of which are removed in a total pancreatectomy. duodenum entire pancreas (removed) spleen STOMACH (kept) hepatic duct → jejunum
The entire pancreas is removed along with the duodenum, distal bile duct, gallbladder, and usually the spleen. The remaining bile duct and stomach are reconnected to the small intestine.

Who is a candidate?

Candidates are patients with diffuse pancreatic disease in whom partial resection (Whipple or distal pancreatectomy) would leave significant cancer, pre-cancer, or destroyed pancreas behind. We also consider total pancreatectomy when, during a planned Whipple, the cut margin shows cancer and an extended resection is the only oncologically sound option. Patients must be cardiopulmonary fit for a major operation, have realistic understanding of the lifelong diabetes and enzyme-replacement requirements, and be willing to engage with endocrine follow-up. We discuss this carefully in multiple pre-op visits.

How we perform it

Total pancreatectomy is performed under general anesthesia, usually through an open upper-abdominal incision; selected cases are done robotically. We mobilize the entire pancreas, divide the relevant blood vessels (gastroduodenal artery, splenic artery and vein), and remove the pancreas en bloc with the duodenum, distal bile duct, gallbladder, regional lymph nodes, and usually the spleen. The remaining bile duct is connected to a loop of jejunum (hepaticojejunostomy), and the stomach is reconnected (gastrojejunostomy). For chronic pancreatitis patients at centers with islet processing, islet cells can be isolated from the removed pancreas and reinfused into the liver to preserve some insulin production. Operations take 6–8 hours.

Recovery

Hospital stay is typically 8–12 days, with the first days spent in a step-down or ICU bed. Insulin is started immediately and titrated with the endocrine team — typically a continuous IV infusion at first, transitioning to subcutaneous insulin (often pump therapy) before discharge. Pancreatic enzyme replacement starts with the first meal and continues for life. Diet advances over weeks. Full recovery to baseline activity takes 2–3 months. The first six months are an adjustment to brittle diabetes; our team and your endocrinologist walk with you closely.

Why Florida Surgical

Total pancreatectomy is among the most consequential operations in HPB surgery. Outcomes depend on a high-volume team, an experienced ICU, careful endocrine planning, and surgeon judgment about when total resection is genuinely the right answer versus a Whipple or distal pancreatectomy. Dr. Shaw is fellowship-trained in surgical oncology and HPB surgery and personally leads every step from initial consultation through long-term follow-up. We coordinate every case with our endocrinology partners so that diabetes management is solid from day one.

Frequently asked questions

Will I have diabetes after a total pancreatectomy?

Yes. Removing the entire pancreas eliminates both insulin and glucagon production, producing brittle diabetes — meaning blood sugars can swing widely without the counter-regulatory hormone glucagon. Lifelong insulin and tight endocrine follow-up are required. Modern insulin pumps and continuous glucose monitors make management much safer than in decades past.

Why might total pancreatectomy be preferred over a Whipple?

When disease is diffuse — main-duct IPMN involving the whole pancreas, multifocal cancer, or hereditary cancer syndromes with field-wide risk — leaving part of the pancreas behind would either leave cancer behind or require a second operation. In those situations, total pancreatectomy is the right answer despite the lifelong diabetes.

Will I need pancreatic enzymes?

Yes. Without the pancreas, you cannot digest food normally — particularly fat. Lifelong pancreatic enzyme replacement (Creon or similar) is required with every meal and snack. Dosing is individualized; our dietitian and endocrinologist help you adjust over the first year.

How long is recovery?

Hospital stay is typically 8–12 days. Recovery to baseline activity takes 2–3 months. The bigger adjustment is to brittle diabetes and enzyme replacement, which takes several months — but with structured education and modern tools, most patients reach a stable regimen.

Is islet autotransplantation an option?

For selected non-cancer cases — severe chronic pancreatitis — islet cells can be isolated from the removed pancreas and reinfused into the liver to preserve some insulin production. This requires a center with islet processing capability and is not appropriate for cancer indications. We refer patients to centers with islet programs when this is the right path.

Diffuse pancreatic disease? Let's plan the right operation.

Request a Consultation